Paritaprevir (b)

CAS No. 1221573-85-8

Paritaprevir (b)( —— )

Catalog No. M10838 CAS No. 1221573-85-8

Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 52 In Stock
25MG 81 In Stock
50MG 140 In Stock
100MG 254 In Stock
200MG 457 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Paritaprevir (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.
  • Description
    Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor. The mechanism of action of paritaprevir is as a HCV NS3/4A Protease Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Breast Y Resistance Protein Inhibitor, and UGT1A1 Inhibitor, and P-Glycoprotein Inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV NS3/4A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1221573-85-8
  • Formula Weight
    765.89
  • Molecular Formula
    C40H43N7O7S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    Cc1ncc(nc1)C(=O)N[C@H]5CCCCCC=C[C@@H]8C[C@]8(NC(=O)[C@@H]6C[C@@H](Oc3nc4ccccc4c2ccccc23)CN6C5=O)C(=O)NS(=O)(=O)C7CC7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Todt D, et al. J Antimicrob Chemother. 2017 Jan 18.
molnova catalog
related products
  • GSK-2485852

    GSK-2485852 (GSK2485852, GSK5852)?is a highly potent, selective HCV NS5B polymerase inhibitor with IC50 of 3.0 and 1.6 nM for HCV genotypes 1a and 1b in replicon assay, respectively.

  • Nucleoside-Analog-1

    A 4′-azidocytidine analogue that shows anti-HCV activity.

  • Ciluprevir

    Ciluprevir (BILN2061) is a potent HCV NS3/4A protease inhibitor with Ki of 0.66 and 0.30 nM for NS3-NS4A protease of HCV 1b and HCV 1a, respectively.